Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07079839 · ClinicalTrials.gov registry record · NA

A Neurosensory Account of Anxiety and Stress (Study 2)

A NA study of Posttraumatic Stress Disorder (PTSD) and Threat-related Sensory Cortical (SC) Disinhibition, sponsored by The University of Texas Health Science Center, Houston.

Recruiting
Registry status
NA
Development phase
160
Enrollment target
1
Study location

NCT07079839 is a NA study of Posttraumatic Stress Disorder (PTSD) and Threat-related Sensory Cortical (SC) Disinhibition that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 160 participants, above the 106-participant average among 17 other Posttraumatic Stress Disorder (PTSD) trials with a reported enrollment target (51% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07079839, a NA study of Posttraumatic Stress Disorder (PTSD) and Threat-related Sensory Cortical (SC) Disinhibition, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.

RECRUITING
Registry status
NA
Development phase
160 participants
Enrollment target
1
Study location

Study Summary

This study will take a basic neuroscience approach to investigate pathological mechanisms underlying PTSD. Additionally, the study aims to identify how Transcranial Alternating Current Stimulation (tACS) brain stimulation can modulate and correct neural networks and related emotions of anxious arousal and hypervigilance, with the goal of assessing tACS brain stimulation technology as a novel intervention for symptoms of anxiety.

Conditions Studied

Posttraumatic Stress Disorder (PTSD) Threat-related Sensory Cortical (SC) Disinhibition

Interventions

  • DEVICE Transcranial Alternating Current Stimulation (tACS)
  • DEVICE Sham for Transcranial Alternating Current Stimulation (tACS)
  • DEVICE Transcranial Random Noise stimulation (tRNS)

Study Locations (1)

Texas

  • The University of Texas Health Science Center at Houston - Houston

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2025-07-03
Est. Completion 2026-07
Phase NA

Sponsor

The University of Texas Health Science Center, Houston

732 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07079839

The ClinicalTrials.gov registry entry for NCT07079839 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 106-participant average among 17 other Posttraumatic Stress Disorder (PTSD) trials with a reported enrollment target (51% higher). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Posttraumatic Stress Disorder (PTSD) appearing as the primary indexed condition, and to 3 interventions - of which Transcranial Alternating Current Stimulation (tACS) is the first listed.

NCT07079839 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT07079839 about?

NCT07079839 is a clinical study titled "A Neurosensory Account of Anxiety and Stress (Study 2)". This study will take a basic neuroscience approach to investigate pathological mechanisms underlying PTSD. Additionally, the study aims to identify how Transcranial Alternating Current Stimulation (tACS) brain stimulation can modulate and correct neural networks and related emotions of anxious arous...

What is the current status of trial NCT07079839?

This trial is currently recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2025-07-03. Estimated completion is 2026-07.

What conditions does trial NCT07079839 study?

This clinical trial studies the following conditions: Posttraumatic Stress Disorder (PTSD), Threat-related Sensory Cortical (SC) Disinhibition.

What interventions are being tested in trial NCT07079839?

The interventions under investigation include: Transcranial Alternating Current Stimulation (tACS) (DEVICE), Sham for Transcranial Alternating Current Stimulation (tACS) (DEVICE), Transcranial Random Noise stimulation (tRNS) (DEVICE).

Who is sponsoring clinical trial NCT07079839?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07079839 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Posttraumatic Stress Disorder (PTSD)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Posttraumatic Stress Disorder (PTSD)

All registered trials for this condition

Threat-related Sensory Cortical (SC) Disinhibition

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.